nutrients-logo

Journal Browser

Journal Browser

Food-Derived Bioactive Peptides, Efficacy, Metabolic Fate, and Mechanisms of Action

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Proteins and Amino Acids".

Deadline for manuscript submissions: 25 September 2024 | Viewed by 1404

Special Issue Editors


E-Mail Website
Guest Editor
Division of Applied Biosciences, Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan
Interests: bioactive peptide; metabolic fate; bioavailability; digestibility of peptides; human health

E-Mail Website
Guest Editor
Department of Food & Nutritional Science, Tokyo Kasei University, 1-18-1 Kaga, Itabashi, Tokyo 173-8602, Japan
Interests: collagen peptide; imidazole dipeptide; valenin; functional food; nutritional science

Special Issue Information

Dear Colleagues,

Bioactive peptides are defined as short amino acid sequences with potential specific physiological functions. It has been demonstrated via animal experiments and human clinical trials that the ingestion of peptides in food protein hydrolysates and fermented foods exerts a wide spectrum of biological functions, including the suppression of metabolic risk factors (hypertension, hyperlipidemia, obesity and peroxidation) and improvement of skin, gut, oral, bone, immune and neurological functions. Some peptides in food have recently been used for therapeutic purposes, while they are classified as food. Such peptides are referred to as food-derived bioactive peptides.

These facts have encouraged researchers to identify active peptides in foods. The activity-guided fractionation based on the high throughput assays is normally used to identify active peptides. Recently, molecular docking analysis and the rapid peptide sequence technique based on liquid chromatography tandem mass spectrometry were utilized for the identification of bioactive peptides in foods. However, there is a deep gap between the concentration of bioactive peptides in foods and the target organ upon ingestion of foods containing peptides, which hinders understanding the mechanisms of action underlying food-derived bioactive peptides. Recent studies have indicated that majority of peptides in foods are further cleaved into smaller peptides and amino acids by peptidases within the gastrointestinal tract, blood and tissues, while few peptides in foods are directly absorbed into the body and reach the target organ. Thus, active peptides in foods may lose potential activity via digestion. On the other hand, inactive peptides in foods may change to bioactive peptides during gastrointestinal digestion. Therefore, understanding the metabolic fate of peptides in foods is crucial for identifying bioactive peptides in the body and understanding their mechanisms of action.

Thus, in this Special Issue, we aim to collect articles and review papers that provide evidence of not only the beneficial nutritional effects of bioactive peptides for human health and disease, but also the mechanisms of action based on the contents in target organs upon ingestion.

Dr. Kenji Sato
Dr. Shigemura Yasutaka
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bioactive peptides
  • peptide absorption
  • oral bioavailability
  • functional foods
  • human health

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

15 pages, 11373 KiB  
Article
Oyster Peptides Ameliorate Dextran Sulfate Sodium-Induced Ulcerative Colitis via Modulating the Gut Microbiota and Inhibiting the TLR4/NF-κB Pathway
by Haixiang Guo, Wenyin Xie, Zhonghao Ji, Bingbing Wang, Wenzhi Ren, Wei Gao and Bao Yuan
Nutrients 2024, 16(11), 1591; https://doi.org/10.3390/nu16111591 - 23 May 2024
Viewed by 506
Abstract
Ulcerative colitis (UC) is an inflammatory bowel disease with an increasing prevalence year over year, and the medications used to treat patients with UC clinically have severe side effects. Oyster peptides (OPs) have anti-inflammatory and antioxidant properties as functional foods that can alleviate [...] Read more.
Ulcerative colitis (UC) is an inflammatory bowel disease with an increasing prevalence year over year, and the medications used to treat patients with UC clinically have severe side effects. Oyster peptides (OPs) have anti-inflammatory and antioxidant properties as functional foods that can alleviate a wide range of inflammatory conditions. However, the application of oyster peptides in ulcerative colitis is not well studied. In this work, an animal model of acute colitis was established using 3% dextran sulfate sodium (DSS), and the impact of OP therapy on colitis in mice was examined. Supplementing with OPs prevented DSS-induced colitis from worsening, reduced the expression of oxidative stress and inflammatory markers, and restored the intestinal barrier damage caused by DSS-induced colitis in mice. The 16S rDNA results showed that the OP treatment improved the gut microbiota structure of the UC mice, including increasing microbial diversity, increasing beneficial bacteria, and decreasing harmful bacteria. In the UC mice, the OP therapy decreased the relative abundance of Family_XIII_AD3011_group and Prevotella_9 and increased the relative abundance of Alistipes. In conclusion, OP treatment can inhibit the TLR4/NF-κB pathway and improve the intestinal microbiota in UC mice, which in turn alleviates DSS-induced colitis, providing a reference for the treatment of clinical UC patients. Full article
Show Figures

Figure 1

Other

Jump to: Research

12 pages, 455 KiB  
Systematic Review
Effects of Hydrolyzed Collagen as a Dietary Supplement on Fibroblast Activation: A Systematic Review
by Pedro Augusto Querido Inacio, Felipe Augusto Chaluppe, Gerson Ferreira Aguiar, Carly de Faria Coelho and Rodolfo P. Vieira
Nutrients 2024, 16(11), 1543; https://doi.org/10.3390/nu16111543 - 21 May 2024
Viewed by 629
Abstract
Background: Our objective was to conduct a systematic review of the effects of hydrolyzed collagen supplementation on the proliferation and activation of fibroblasts. Methods: The search was conducted for journals that published articles in the English language, peer-reviewed, meeting the following criteria: (a) [...] Read more.
Background: Our objective was to conduct a systematic review of the effects of hydrolyzed collagen supplementation on the proliferation and activation of fibroblasts. Methods: The search was conducted for journals that published articles in the English language, peer-reviewed, meeting the following criteria: (a) randomized clinical trials, (b) randomized studies in animals or humans, (c) in vitro studies, (d) studies using hydrolyzed collagens or collagen peptides, and (e) studies assessing alterations on fibroblasts as the primary or secondary outcome. We utilized the main journal databases PubMed/Web of Science and ongoing reviews by PROSPERO. For bias risk and methodological quality, we used an adaptation of the Downs and Black checklist. Our review followed the PRISMA checklist, conducted from February 2024 to the first week of March 2024, by two independent researchers (P.A.Q.I. and R.P.V.). Results: Eleven studies were included in this review, where our findings reinforce the notion that hydrolyzed collagens or collagen peptides at concentrations of 50–500 μg/mL are sufficient to stimulate fibroblasts in human and animal tissues without inducing toxicity. Different enzymatic processes may confer distinct biological properties to collagens, allowing for scenarios favoring fibroblast promotion or antioxidant effects. Lastly, collagens with lower molecular weights exhibit greater bioavailability to adjacent tissues. Conclusions: Hydrolyzed collagens or collagen peptides with molecular sizes ranging from <3 to 3000 KDa promote the stimulation of fibroblasts in human tissues. Full article
Show Figures

Figure 1

Back to TopTop